08/07/2024 Healthcare
Vidasat-M tablets combine Vildagliptin and Metformin Hydrochloride to manage type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that increases insulin secretion and decreases glucagon levels, while Metformin reduces glucose production in the liver and improves insulin sensitivity. This combination effectively controls blood sugar levels. Dosage should be directed by a healthcare provider to ensure optimal diabetes management and minimize side effects.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations
Vidasat-M tablets combine Vildagliptin and Metformin Hydrochloride to manage type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that increases insulin...
**Sitamin D** combines Dapagliflozin, Sitagliptin, and Metformin Hydrochloride in tablet form for comprehensive diabetes management. Dapagliflozin hel...
Ecotin SR tablets combine Teneligliptin (20 mg) and Metformin Hydrochloride (500 mg) for managing type 2 diabetes. Teneligliptin is a DPP-4 inhibitor ...
Vildagliptin and metformin are two medications that are combined to treat type 2 diabetes mellitus. This medication helps regulate blood sugar levels ...
More Details